Thermo Fisher Buys SwissAnalytic; Regis expands services with SFC; PerkinElmer acquires product line from Triton; Airgas acquires CFC Refimax
Thermo Fisher Buys SwissAnalytic
Thermo Fisher Scientific, Inc. (Waltham, Massachusetts) announced it has acquired SwissAnalytic Group AG (Basel, Switzerland), which owns Spectronex AG and Flux Instruments AG.
Spectronex is a supplier of mass spectrometry, chromatography, and surface science instrumentation in Switzerland, Austria, Slovakia, and the Czech Republic. Flux Instruments is a manufacturer of high performance liquid chromatography (HPLC) pumps and software.
Thermo Fisher Scientific's current HPLC and liquid chromatography coupled mass spectroscopy business includes its Accela high-speed liquid chromatograph IC system and advanced sample extraction and LC products gained when it acquired Massachusetts-based Cohesive Technologies, Inc., a manufacturer of advanced sample extraction and liquid chromatography products, in December.
Regis expands services with SFC
Regis Technologies, Inc. (Morton Grove, Illinois) announced the addition of supercritical fluid chromatography (SFC) to its separations services and will offer GMP separations in April 2007.
The new service marries SFC with the company's chiral HPLC services and products. Regis has long served the analytical and preparative markets with its chromatography products including their proprietary chiral stationary phases.
Regis will use the Thar SFC Method Station equipment with Regis and other chiral stationary phases, and have agreed to be a host demonstration partner for Thar systems.
PerkinElmer acquires product line from Triton
PerkinElmer, Inc. (Wellesley, Massachusetts) announced the acquisition of a line of dynamic mechanical analysis (DMA) products from Triton Technology Limited (Nottinghamshire, United Kingdom). The DMA instrument is used by scientists in the polymers, pharmaceuticals, and food industries for diverse applications ranging from simple quality control to advanced research.
"This acquisition brings our customers a best-in-class thermal analysis tool that combines ease-of-use and flexibility with powerful performance," said Robert F. Friel, president of PerkinElmer Life and Analytical Sciences. "The new DMA 8000 represents the type of novel, next-generation technology we are investing in to continually provide solutions to customers that enable them to advance the pace and precision of their research and testing."
Airgas acquires CFC Refimax
Airgas, Inc. (Radnor, Pennsylvania) announced the acquisition of CFC Refimax, LLC (Atlanta, Georgia), a leading full-service refrigerant supplier and reclamation company. The business generated about $21 million in annual sales in 2006.
Refimax has been integrated into Airgas Specialty Products, a national distributor of ammonia products and services, various process chemicals, and refrigerants.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.